Form 4 for TCRX TScan Therapeutics, Inc.

Accepted 2021-07-22 00:00:00 ET · period of report 2021-07-20 · accession 0000899243-21-029440 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-07-22	2021-07-20	TCRX	BARBERICH TIMOTHY J	Dir	C - Cnv Deriv	—	+33.3K	33.3K	New	—
D	2021-07-22	2021-07-20	TCRX	BARBERICH TIMOTHY J	Dir	C - Cnv Deriv	—	-33.3K	0	-100%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Voting Common Stock	2021-07-20	C	A	33,259	—	33,259	D	—	—	(F1) Each share of the Issuer's Series B Preferred Stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.
2	Derivative	Series B Preferred Stock	2021-07-20	C	D	33,259	—	0	D	— · — to —	33,259 Voting Common Stock	(F1) Each share of the Issuer's Series B Preferred Stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.